7Baggers

Edwards Lifesciences Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Long-Term Debt  
 Inventory  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 00.531.051.582.12.633.153.68Billion

Edwards Lifesciences Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2007-09-30 2007-06-30 2007-03-31 2006-09-30 2006-06-30 2006-03-31 2005-09-30 2005-06-30 
                                                    
  assets                                                  
  current assets                                                  
  cash and cash equivalents3,272,800,000 3,140,600,000 3,045,200,000 3,676,400,000 1,644,500,000 1,224,600,000 1,144,000,000 1,410,100,000 1,042,600,000 872,500,000 769,000,000 1,247,800,000 1,198,100,000 1,030,900,000 862,800,000 1,506,900,000 1,312,800,000 1,174,200,000 1,183,200,000 1,024,000,000 903,500,000 662,900,000 1,179,100,000 1,186,600,000 726,800,000 709,200,000 714,100,000 1,261,300,000 1,226,400,000 1,227,000,000 818,300,000 630,300,000 508,200,000 819,300,000 930,100,000 645,000,000 369,900,000 501,400,000 718,400,000 646,100,000 597,600,000 457,000,000  164,900,000 180,200,000 151,300,000 167,100,000 189,200,000 88,000,000 96,100,000 
  short-term investments789,400,000 757,900,000 930,700,000 769,700,000 345,300,000 473,000,000 500,500,000 453,800,000 466,700,000 381,700,000 446,300,000 490,900,000 317,700,000 465,000,000 604,000,000 287,800,000 248,400,000 156,400,000 219,400,000 271,300,000 260,300,000 368,200,000 337,800,000 170,300,000 207,500,000 253,800,000 242,400,000 334,400,000 174,400,000 272,300,000 519,200,000 772,500,000 623,600,000 98,900,000 341,000,000 555,300,000 690,300,000 450,400,000 506,300,000 604,400,000 811,400,000 913,800,000         
  accounts receivable697,000,000 669,200,000 609,100,000 716,000,000 778,300,000 817,600,000 775,100,000 739,800,000 754,400,000 717,700,000 643,000,000 618,100,000 636,400,000 636,300,000 582,200,000 600,600,000 640,500,000 586,600,000 514,600,000 549,700,000   543,600,000    456,900,000 423,800,000 431,400,000 406,600,000 421,600,000    365,500,000    315,400,000            
  other receivables205,600,000 82,700,000 118,300,000 95,500,000 56,100,000 59,300,000 61,800,000 62,300,000 62,500,000 61,600,000 56,100,000 43,300,000 42,800,000 49,900,000 82,700,000 63,600,000 59,800,000 77,700,000 88,200,000 122,000,000   55,500,000    80,400,000 106,300,000 88,700,000 40,200,000 40,600,000    49,100,000    28,700,000            
  inventories1,141,700,000 1,113,900,000 1,086,700,000 1,104,200,000 1,024,700,000 1,207,300,000 1,168,200,000 1,032,400,000 980,200,000 914,300,000 875,500,000 757,800,000 740,000,000 730,600,000 726,700,000 737,800,000 759,500,000 767,900,000 802,300,000 773,300,000 735,100,000 662,200,000 640,900,000 611,100,000 624,900,000 630,900,000 607,000,000 583,800,000 568,100,000 573,900,000 554,900,000 538,400,000 491,600,000 431,400,000 396,600,000 401,000,000 367,600,000 356,600,000 339,900,000 333,500,000 313,300,000 298,500,000  143,500,000 141,500,000 148,900,000 139,000,000 135,000,000 135,500,000 131,300,000 
  prepaid expenses110,000,000 111,300,000 121,000,000 114,900,000 110,200,000 138,100,000 146,800,000 133,300,000 123,200,000 119,100,000 110,000,000 88,400,000 79,300,000 94,100,000 85,200,000 76,900,000 68,600,000 77,300,000 75,100,000 68,600,000 57,300,000 65,800,000 59,100,000 57,300,000 55,700,000 55,400,000 54,300,000 52,600,000 69,900,000 78,000,000 60,600,000 52,800,000 54,100,000 53,000,000 45,900,000 49,800,000 50,000,000 48,800,000 45,100,000 47,500,000 46,100,000 44,800,000         
  other current assets314,400,000 304,500,000 347,600,000 231,000,000 252,100,000 250,600,000 239,300,000 235,800,000 217,400,000 190,300,000 195,900,000 267,600,000 248,800,000 234,500,000 237,100,000 241,900,000 233,300,000 229,100,000 208,200,000 171,500,000 166,200,000 163,700,000 168,000,000 144,400,000 130,200,000 141,500,000 131,800,000 150,400,000 137,100,000 118,900,000 116,900,000 97,400,000 95,200,000 105,600,000 111,800,000 66,100,000 81,500,000 73,600,000 94,100,000 96,600,000 112,400,000 138,400,000         
  current assets of discontinued operations46,300,000 32,600,000 26,800,000 20,000,000 304,800,000                                              
  total current assets6,577,200,000 6,212,700,000 6,285,400,000 6,727,700,000 4,516,000,000 4,170,500,000 4,035,700,000 4,067,500,000 3,647,000,000 3,257,200,000 3,095,800,000 3,513,900,000 3,263,100,000 3,241,300,000 3,180,700,000 3,515,500,000 3,322,900,000 3,069,200,000 3,091,000,000 2,980,400,000 2,690,300,000 2,507,900,000 2,984,000,000 2,739,700,000 2,354,700,000 2,368,800,000 2,286,900,000 2,912,600,000 2,696,000,000 2,716,900,000 2,532,100,000 2,566,400,000 2,283,400,000 2,018,400,000 2,240,000,000 2,171,400,000 1,985,100,000 1,819,300,000 2,047,900,000 2,145,500,000 2,297,000,000 2,254,800,000  541,200,000 542,100,000 524,900,000 542,300,000 526,100,000 430,400,000 437,100,000 
  long-term investments298,500,000 277,900,000 307,900,000 319,600,000 353,300,000 455,600,000 583,900,000 704,600,000 856,200,000 1,066,700,000 1,239,000,000 1,381,000,000 1,490,800,000 1,623,700,000 1,834,200,000 1,282,000,000 1,014,200,000 802,200,000 801,600,000 599,000,000 594,400,000 587,800,000 585,500,000 386,000,000 412,900,000 453,700,000 506,300,000 479,000,000 470,400,000 532,100,000 567,000,000 567,500,000 551,500,000 519,000,000 532,100,000 467,500,000 391,700,000 369,200,000 379,900,000 366,000,000 324,600,000 255,600,000         
  property, plant, and equipment1,726,600,000 1,698,300,000 1,686,000,000 1,675,700,000 1,640,100,000 1,767,900,000 1,749,400,000 1,681,300,000 1,662,200,000 1,646,000,000 1,632,800,000 1,566,400,000 1,559,900,000 1,552,200,000 1,546,600,000 1,464,600,000 1,445,800,000 1,417,900,000 1,395,200,000 1,276,300,000 1,195,600,000 1,100,600,000 1,060,300,000 973,600,000 931,100,000 892,200,000 867,500,000 826,100,000 770,200,000 711,600,000 679,700,000 649,600,000 627,900,000 588,800,000 580,000,000 543,700,000 516,200,000 497,300,000 482,500,000 454,800,000 450,600,000 445,100,000         
  operating lease right-of-use assets99,000,000 96,900,000 98,200,000 104,400,000 92,800,000 98,400,000 94,000,000 90,900,000 84,900,000 88,500,000 92,300,000 87,700,000 84,200,000 90,100,000 92,100,000 84,800,000 84,600,000 88,500,000 94,200,000 89,500,000 84,700,000 75,500,000 80,100,000 73,300,000 71,200,000 69,900,000                         
  goodwill1,776,700,000 1,778,700,000 1,776,700,000 1,605,300,000 1,151,000,000 1,252,800,000 1,253,500,000 1,297,400,000 1,299,500,000 1,308,400,000 1,164,300,000 1,158,700,000 1,164,100,000 1,166,300,000 1,167,900,000 1,170,400,000 1,171,800,000 1,170,800,000 1,173,200,000 1,170,000,000 1,167,700,000 1,166,200,000 1,167,700,000 1,156,600,000 1,173,900,000 1,103,400,000 1,112,200,000 1,122,300,000 1,118,600,000 1,144,800,000 1,126,500,000 980,500,000 965,100,000 945,200,000 626,100,000 630,000,000 629,400,000 630,900,000 628,300,000 621,200,000 370,900,000 368,400,000  337,700,000 337,700,000 337,700,000 337,700,000 337,700,000 337,700,000 337,700,000 
  other intangible assets1,172,800,000 1,174,900,000 1,176,600,000 956,100,000 417,100,000 446,800,000 428,400,000 429,800,000 431,400,000 446,800,000 285,200,000 266,500,000 320,700,000 322,000,000 323,600,000 325,300,000 327,000,000 330,300,000 331,400,000 332,400,000 333,500,000 334,800,000 336,500,000 381,100,000 385,600,000 341,300,000 343,200,000 467,900,000 466,000,000 480,500,000 468,000,000 414,900,000 408,600,000 402,100,000 204,800,000 207,000,000 208,700,000 203,700,000 205,400,000 207,300,000 18,900,000 20,500,000  107,500,000 108,900,000 123,200,000 127,500,000 133,300,000 141,800,000 145,900,000 
  deferred income taxes1,082,100,000 1,027,800,000 992,100,000 888,400,000 832,600,000 776,700,000 754,600,000 651,900,000 610,700,000 544,000,000 484,000,000 347,500,000 307,600,000 294,900,000 246,700,000 184,000,000 190,500,000 209,300,000 230,900,000 215,200,000 204,100,000 158,000,000 172,200,000 155,800,000 163,800,000 164,500,000 174,000,000 115,100,000 130,100,000 181,400,000 213,600,000 197,100,000 185,200,000 179,100,000 203,800,000 189,300,000 188,600,000 196,500,000 180,500,000 79,000,000 65,200,000 57,000,000  25,400,000 26,800,000 29,200,000 30,600,000 24,700,000 13,900,000 15,000,000 
  other assets743,000,000 742,700,000 721,600,000 683,500,000 789,800,000 767,600,000 463,700,000 447,400,000 412,100,000 293,600,000 299,100,000 316,500,000 234,700,000 129,400,000 110,800,000 133,700,000 105,300,000 125,500,000 119,600,000 138,000,000 153,800,000 145,300,000 101,800,000 100,200,000 80,300,000 75,500,000 33,600,000 35,200,000 34,800,000 57,800,000 108,900,000 112,400,000 116,800,000 127,800,000 123,200,000 124,800,000 126,400,000 131,100,000 131,200,000 54,900,000 57,700,000 53,400,000  15,300,000 15,300,000 13,200,000 13,000,000 15,500,000 9,600,000 9,800,000 
  non-current assets of discontinued operations12,800,000 12,400,000 10,800,000 10,500,000 306,600,000                                              
  total assets13,488,700,000 13,022,300,000 13,055,300,000 12,971,200,000 10,099,300,000 9,736,300,000 9,363,200,000 9,370,800,000 9,004,000,000 8,651,200,000 8,292,500,000 8,638,200,000 8,425,100,000 8,419,900,000 8,502,600,000 8,160,300,000 7,662,100,000 7,213,700,000 7,237,100,000 6,800,800,000 6,424,100,000 6,076,100,000 6,488,100,000 5,966,300,000 5,573,500,000 5,469,300,000 5,323,700,000 5,958,200,000 5,686,100,000 5,825,100,000 5,695,800,000 5,488,400,000 5,138,500,000 4,780,400,000 4,510,000,000 4,339,000,000 4,051,400,000 3,853,800,000 4,059,300,000 3,876,600,000 3,608,300,000 3,488,400,000         
  liabilities and stockholders' equity                                                  
  current liabilities                                                  
  accounts payable162,100,000 172,400,000 197,400,000 172,800,000 185,900,000 212,300,000 201,400,000 190,600,000 193,000,000 180,800,000 201,900,000 154,900,000 162,500,000 158,800,000 204,500,000 139,500,000   196,500,000    180,400,000    134,000,000    116,600,000    97,100,000    63,900,000            
  accrued and other liabilities1,214,400,000 1,196,400,000 1,282,400,000 1,745,300,000 902,400,000 873,700,000 969,100,000 1,024,000,000 939,900,000 876,100,000 795,000,000 739,500,000 783,300,000 767,200,000 802,300,000 802,800,000   670,200,000    696,500,000    742,600,000    636,600,000    435,400,000    412,300,000            
  operating lease liabilities25,900,000 23,700,000 23,400,000 24,200,000 21,500,000 24,800,000 24,900,000 24,300,000 24,300,000 25,100,000 25,500,000 23,500,000 23,300,000 23,900,000 25,500,000 24,200,000 25,100,000 26,500,000 27,200,000 24,200,000 23,800,000 24,900,000 25,500,000 24,100,000 23,800,000 22,600,000                         
  current liabilities of discontinued operations2,300,000 2,300,000 2,000,000 1,800,000 107,200,000                                              
  total current liabilities1,404,700,000 1,394,800,000 1,505,200,000 1,944,100,000 1,217,000,000 1,110,800,000 1,195,400,000 1,238,900,000 1,157,200,000 1,082,000,000 1,022,400,000 917,900,000 969,100,000 949,900,000 1,032,300,000 966,500,000 886,200,000 799,000,000 893,900,000 846,300,000 873,200,000 746,900,000 902,400,000 775,800,000 697,000,000 646,500,000 876,600,000 1,261,100,000 1,183,200,000 1,314,500,000 1,402,900,000 735,200,000   532,500,000    476,200,000     323,600,000       
  long-term debt598,000,000 597,800,000 597,700,000 597,500,000 597,300,000 597,200,000 597,000,000 596,800,000 596,700,000 596,500,000 596,300,000 596,200,000 596,000,000 595,900,000 595,700,000 595,500,000 595,400,000 595,200,000 595,000,000 594,900,000 594,700,000 594,600,000 594,400,000 594,200,000 594,100,000 593,900,000 593,800,000 593,600,000 593,900,000 456,000,000 438,400,000 1,034,000,000 1,016,800,000 847,900,000 822,300,000 600,600,000 602,500,000 602,200,000 599,900,000 604,900,000 600,300,000 602,700,000  57,600,000 224,500,000 253,000,000 279,600,000 288,800,000 251,500,000 269,600,000 
  uncertain tax positions421,600,000 402,600,000 384,600,000 345,600,000 343,200,000 336,600,000 339,300,000 312,100,000 303,700,000 284,000,000 267,500,000 295,600,000 282,400,000 270,700,000 259,000,000 245,400,000 234,200,000 224,200,000 214,400,000 199,200,000 181,300,000 175,900,000 171,700,000 141,700,000 139,500,000 130,300,000 124,900,000    164,600,000    229,800,000    194,700,000            
  other liabilities379,200,000 357,600,000 357,500,000 322,600,000 257,100,000 266,500,000 264,300,000 240,300,000 242,700,000 260,100,000 217,500,000 221,100,000 222,200,000 259,700,000 267,300,000 275,500,000 268,400,000 250,800,000  484,000,000                               
  total liabilities2,882,200,000 2,830,700,000 2,992,400,000 3,359,800,000 2,594,700,000 2,549,900,000 2,643,800,000 2,643,700,000 2,557,500,000 2,589,200,000 2,485,800,000 2,420,400,000 2,481,500,000 2,575,000,000 2,666,700,000 2,619,000,000                                   
  commitments and contingencies                                                  
  stockholders' equity                                                  
  preferred stock, 0.01 par value, authorized 50.0 shares, no shares outstanding                                                  
  common stock657,600,000 655,900,000 654,800,000 654,300,000 653,500,000 651,800,000 650,500,000 649,900,000 649,100,000 647,100,000 646,300,000 645,700,000 645,000,000 642,900,000 642,000,000 641,200,000 640,100,000 637,500,000 636,400,000 635,000,000 633,500,000 218,500,000 218,100,000 217,500,000 216,900,000 216,000,000 215,200,000 214,800,000 214,000,000 213,000,000 212,000,000 211,600,000 244,700,000 243,200,000 242,600,000 242,000,000 241,000,000 239,800,000 239,100,000 130,200,000 129,900,000 129,400,000  67,900,000 67,600,000 66,700,000 66,300,000 65,900,000 65,400,000 65,000,000 
  additional paid-in capital2,750,000,000 2,653,200,000 2,613,400,000 2,452,100,000 2,476,300,000 2,379,800,000 2,274,400,000 2,211,300,000 2,145,500,000 2,049,300,000 1,969,300,000 1,914,500,000 1,852,500,000 1,769,400,000 1,700,400,000 1,643,100,000 1,578,700,000 1,496,800,000 1,438,100,000 1,381,600,000 1,323,900,000 1,675,900,000 1,623,300,000 1,570,400,000 1,512,300,000 1,449,400,000 1,384,400,000 1,341,200,000 1,209,500,000 1,229,100,000 1,166,900,000 1,129,500,000 1,267,000,000 1,207,600,000 1,167,800,000 1,091,100,000 1,020,200,000 933,400,000 946,800,000 1,001,300,000 964,100,000 925,000,000         
  retained earnings13,858,200,000 13,525,000,000 13,167,000,000 12,781,400,000 9,710,600,000 9,344,300,000 8,992,400,000 8,622,500,000 8,237,600,000 7,930,500,000 7,590,000,000 7,191,600,000 6,848,100,000 6,441,700,000 6,068,100,000 5,732,800,000 5,392,700,000 4,903,200,000 4,565,000,000 4,255,500,000 3,930,300,000 4,052,200,000 3,741,600,000 3,461,400,000 3,186,700,000 2,944,400,000 2,694,700,000 2,687,700,000 2,461,800,000 2,179,100,000 1,962,100,000 1,964,900,000 4,331,900,000 4,145,800,000 3,906,300,000 3,747,800,000 3,606,400,000 3,479,800,000 3,336,800,000 3,196,100,000 3,078,000,000 2,965,300,000  503,700,000 468,800,000 413,200,000 385,400,000 349,300,000 264,700,000 269,100,000 
  accumulated other comprehensive loss-264,100,000 -254,500,000 -244,500,000 -252,500,000 -220,200,000 -233,300,000 -242,800,000 -250,100,000 -255,500,000 -255,400,000 -254,900,000 -256,000,000 -224,400,000 -186,600,000 -157,700,000 -155,400,000 -159,600,000 -172,400,000 -161,100,000 -157,900,000 -146,100,000 -152,000,000 -156,000,000 -155,800,000 -138,200,000 -141,200,000 -138,500,000 -139,000,000 -150,800,000 -121,300,000 -132,700,000 -142,700,000 -157,800,000 -181,500,000 -198,400,000 -171,200,000 -178,700,000 -172,600,000 -182,600,000 -169,200,000 -146,600,000 -147,900,000   -13,800,000 -19,200,000  -19,600,000 -22,500,000  
  treasury stock-6,456,400,000 -6,450,900,000 -6,192,300,000 -6,089,700,000 -5,182,800,000 -5,024,700,000 -5,024,500,000 -4,576,100,000 -4,401,000,000 -4,393,500,000 -4,144,000,000 -3,278,000,000 -3,177,600,000 -2,822,500,000 -2,416,900,000 -2,320,400,000 -2,318,600,000 -2,206,700,000 -1,904,100,000 -1,903,900,000 -1,902,500,000 -1,893,500,000 -1,278,700,000 -1,278,700,000 -1,277,400,000 -1,021,100,000 -1,015,400,000 -743,400,000 -570,300,000 -254,200,000 -252,100,000 -800,000 -2,746,200,000 -2,672,400,000 -2,499,300,000 -2,217,900,000 -2,217,700,000 -2,181,100,000 -1,837,000,000 -1,737,000,000 -1,736,800,000 -1,657,900,000   -364,200,000 -320,700,000  -222,900,000   
  total edwards lifesciences corporation stockholders' equity10,545,300,000 10,128,700,000 9,998,400,000 9,545,600,000 7,437,400,000 7,117,900,000 6,650,000,000 6,657,500,000 6,375,700,000                                          
  noncontrolling interest61,200,000 62,900,000 64,500,000 65,800,000 67,200,000 68,500,000 69,400,000 69,600,000 70,800,000 84,000,000                                         
  total stockholders' equity10,606,500,000 10,191,600,000 10,062,900,000 9,611,400,000 7,504,600,000 7,186,400,000 6,719,400,000 6,727,100,000 6,446,500,000 6,062,000,000 5,806,700,000 6,217,800,000 5,943,600,000 5,844,900,000 5,835,900,000 5,541,300,000 5,133,300,000 4,658,400,000 4,574,300,000 4,210,300,000 3,839,100,000 3,901,100,000 4,148,300,000 3,814,800,000 3,500,300,000 3,447,500,000 3,140,400,000 3,361,300,000 3,164,200,000 3,245,700,000 2,956,200,000 3,162,500,000 2,939,600,000 2,742,700,000 2,619,000,000 2,691,800,000 2,471,200,000 2,299,300,000 2,503,100,000 2,421,400,000 2,288,600,000 2,213,900,000         
  total liabilities and equity13,488,700,000 13,022,300,000 13,055,300,000 12,971,200,000 10,099,300,000 9,736,300,000  9,370,800,000 9,004,000,000 8,651,200,000                                         
  contingent consideration liabilities  14,500,000       26,900,000 26,200,000 25,700,000 38,200,000 59,100,000 62,000,000 80,100,000 79,000,000 181,600,000 186,100,000 180,900,000 189,900,000 170,300,000 172,500,000 191,000,000 193,300,000 185,300,000    41,800,000 51,700,000 41,500,000 198,700,000 195,600,000                 
  taxes payable  1,300,000 1,100,000 1,100,000 79,600,000 80,600,000 81,200,000 81,200,000 143,400,000 143,400,000 142,900,000 142,900,000 190,000,000 190,000,000 190,200,000 190,200,000 215,300,000 215,300,000 214,200,000 214,200,000 239,300,000 236,600,000 236,500,000 236,700,000 259,400,000 259,400,000 264,500,000 263,300,000 290,800,000 394,000,000                    
  litigation settlement accrual  52,700,000 63,900,000 74,800,000 82,000,000 94,200,000 104,400,000 112,500,000  143,000,000 153,900,000 167,200,000 181,300,000 191,300,000 201,400,000 211,700,000 222,100,000 233,000,000                                
  non-current liabilities of discontinued operations    30,000,000                                              
  total liabilities and stockholders' equity      9,363,200,000    8,292,500,000 8,638,200,000 8,425,100,000 8,419,900,000 8,502,600,000 8,160,300,000 7,662,100,000 7,213,700,000 7,237,100,000 6,800,800,000 6,424,100,000 6,076,100,000 6,488,100,000 5,966,300,000 5,573,500,000 5,469,300,000 5,323,700,000 5,958,200,000 5,686,100,000 5,825,100,000 5,695,800,000 5,488,400,000 5,138,500,000 4,780,400,000 4,510,000,000 4,339,000,000 4,051,400,000 3,853,800,000 4,059,300,000 3,876,600,000 3,608,300,000 3,488,400,000         
  litigation agreement accrual         130,100,000                                         
  total edwards lifesciences, inc. stockholders' equity         5,978,000,000                                         
  accounts payable and accrued liabilities                861,100,000 772,500,000  822,100,000 849,400,000 722,000,000  751,700,000 673,200,000 623,900,000  661,200,000 584,000,000 674,100,000  693,700,000 562,500,000 584,800,000  532,800,000 478,200,000 458,300,000  532,500,000 445,200,000 405,300,000  173,600,000 179,400,000 227,500,000 226,500,000 196,500,000 204,600,000 190,400,000 
  other long-term liabilities                  252,400,000  465,700,000 192,300,000 203,300,000 159,900,000 162,200,000 156,700,000 150,000,000 285,100,000 282,500,000 321,800,000 147,100,000 416,200,000 420,900,000 409,400,000 306,400,000 513,800,000 499,500,000 494,000,000 285,400,000 317,800,000 274,200,000 266,500,000  63,100,000 60,300,000 31,900,000 30,700,000 30,700,000 29,700,000 29,100,000 
  preferred stock, .01 par value, authorized 50.0 shares, no shares outstanding                                                  
  accounts and other receivables, net of allowances of 9.3 and 8.7, respectively                    567,900,000                              
  accounts and other receivables, net of allowances of 9.0 and 8.7, respectively                     585,100,000                             
  accounts and other receivables, net of allowances of 8.8 and 8.9, respectively                       570,000,000 609,600,000                          
  accounts and other receivables, net of allowances of 8.6 and 8.9, respectively                         578,000,000                         
  short-term debt                           599,900,000 599,200,000 598,600,000 598,000,000                    
  accounts and other receivables, net of allowances of 9.4 and 9.0, respectively                               475,000,000                   
  accounts and other receivables, net of allowances of 8.5 and 9.0, respectively                                510,700,000                  
  accounts and other receivables, net of allowances of 8.6 and 9.0, respectively                                 510,200,000                 
  accounts and other receivables, net of allowances of 7.7 and 6.8, respectively                                   454,200,000               
  long-term accounts receivable, net of allowances of 6.6 and 6.3, respectively                                   5,300,000 5,300,000              
  accounts and other receivables, net of allowances of 6.7 and 6.8, respectively                                    425,800,000              
  accounts and other receivables, net of allowances of 7.2 and 6.8, respectively                                     388,500,000             
  long-term accounts receivable, net of allowances of 6.5 and 6.3, respectively                                     5,800,000             
  long-term accounts receivable                                      3,600,000            
  accounts and other receivables, net of allowances of 8.2 and 5.1, respectively                                       338,400,000           
  long-term accounts receivable, net of allowances of 5.5 and 6.2, respectively                                       5,500,000 6,600,000          
  accounts and other receivables, net of allowances of 8.1 and 5.1, respectively                                        351,000,000          
  accounts and other receivables, net of allowances of 5.6 and 5.1, respectively                                         345,300,000         
  long-term accounts receivable, net of allowances of 5.4 and 6.2, respectively                                         5,700,000         
  accounts and other receivables, net of allowances of 7.0 and 6.5, respectively                                           137,400,000       
  prepaid expenses and other current assets                                           70,000,000 64,300,000 65,300,000 71,900,000 54,400,000 67,100,000 69,800,000 
  property, plant and equipment                                           220,200,000 216,700,000 211,500,000 205,700,000 199,200,000 192,100,000 193,000,000 
  investments in unconsolidated affiliates                                           25,100,000 22,200,000 14,300,000 16,000,000 14,000,000 14,500,000 14,100,000 
  liabilities and stockholders’ equity                                                  
  convertible debt                                           150,000,000       
  stockholders’ equity                                                  
  additional contributed capital                                           644,000,000 626,600,000 587,900,000 570,500,000 550,800,000 528,000,000 517,500,000 
  total stockholders’ equity                                           807,500,000 785,000,000 727,900,000 722,400,000 723,500,000 659,200,000 661,700,000 
  accounts and other receivables, net of allowances of 6.4 and 6.5, respectively                                            129,300,000      
  accounts and other receivables, net of allowances of 6.3 and 5.4, respectively                                             130,200,000     
  accounts and other receivables, net of allowances of 6.2 and 5.4, respectively                                              133,700,000    
  accounts and other receivables, net of allowances of 5.4 and 5.4, respectively                                               122,800,000   
  accounts and other receivables, net of allowances of 5.3 and 5.2, respectively                                                125,900,000  
  common stock in treasury, at cost, 5,635,000 and 4,804,600 shares at september 30, 2005 and december 31, 2004, respectively                                                -176,400,000  
  accounts and other receivables, net of allowances of 5.5 and 5.2, respectively                                                 124,900,000 
  accumulated other comprehensive income                                                  
  common stock in treasury, at cost, 5,174,600 and 4,804,600 shares at june 30, 2005 and december 31, 2004, respectively                                                  

We provide you with 20 years of balance sheets for Edwards Lifesciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Edwards Lifesciences. Explore the full financial landscape of Edwards Lifesciences stock with our expertly curated balance sheets.

The information provided in this report about Edwards Lifesciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.